New surgical patch aims to stop bleeding faster in open surgery

NCT ID NCT06664788

Recruiting now Disease control Sponsor: Ethicon, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study compares a new product called ETHIZIA to an existing one, SURGICEL, for controlling minor to moderate bleeding during open surgery on the abdomen, chest, or limbs. About 108 adults having planned open surgery will be enrolled. The main goal is to see if ETHIZIA stops bleeding within 3 minutes and keeps it stopped for at least 10 minutes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOSTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMOSTASIS HEMOSTATIC TECHNIQUES

Contacts and locations

Locations

Capital Health Medical Center - Hopewell
RECRUITING

Pennington, New Jersey, 08534, United States
Intermountain Medical Center
RECRUITING

Murray, Utah, 84107, United States
Keck Hospital of USC
RECRUITING

Los Angeles, California, 90033, United States
New York Presbyterian - Weill Cornell Medical Ctr
RECRUITING

New York, New York, 10065, United States
UMC Radboud
RECRUITING

Nijmegen, 6500HB, Netherlands
UT Health East Texas EMS Air 1
RECRUITING

Tyler, Texas, 75701, United States
Washington University Barnes Jewish Hospital
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.